Made in USA Pharma Supply Chain Amendment Passes Unanimously
Sen. Tina Smith’s bill to provide $500 million in grants for domestic pharmaceutical manufacturers passes with flying colors and will be part of PREVENT Pandemics Act.
House Hearing on FDA: Advanced Manufacturing May – or May Not – Lead to Domestic Manufacturing Boom
The House Committee on Energy and Commerce discussed FDA’s user fee budget and what can be done to reshore more of the pharmaceutical industry.
We Need to be Better at Industrial Policy
We Need to be Better at Industrial Policy By Amanda Mayoral, CPA Economist Industrial policy is critical to competing in a global economy and
Global Pharma Supply Chain Survey Shows Free Trade Not The Solution
Free trade loses out to a bigger government role in securing domestic supply chains of critical medication.
House Committee Hearing on Small Business Supply Chains Forgets About Reshoring
A House committee hearing on the impact of the supply crisis on small businesses left out one key solution: import less, make more here.
Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman
CPA’s report, titled “Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman,” details how a loophole
New CPA Report Documents How Hatch-Waxman Act Loophole Led to Offshoring of Generics Production, Price Gouging, and Shortages
WASHINGTON — The Coalition for a Prosperous America (CPA) today released a new academic report that details how a loophole in the Hatch-Waxman Act has
Tainted Blood Pressure Medication from India Can ‘Change Someone’s DNA’
An Indian drug market that’s been the subject of FDA warnings since 2017 is the apparent source of tainted medication sold in the U.S. and Canada. This is another example as to why we need to reshore critical supply of essential medication. Where is Congress?
Senate Hearing On Medical Supplies: “US Companies No Longer Getting PPE Orders. It’s Mostly Going To China”
Here we go again. Textile companies that spent money on retooling to make masks and hospital gowns now losing to China dumping PPE in the U.S.
Making The Case For Reshoring Critical Drugs, Where 90% Of Inputs Are In China’s Hands
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
